Investors

Perrigo is uniquely positioned as the only global company with a mix of generic over-the-counter and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients, delivering value by meeting the growing need for "Quality Affordable Healthcare Products®."

FY15 - Recast Exhibits can be found here.
(1.04MB)


print email rss
Price Data
NYSEPRGO
Key Contacts
Bradley Joseph
Vice President, Global Investor Relations
269-686-3373
bradley.joseph@perrigo.com
Arthur J. Shannon, Vice President
Global Corporate Affairs and European Investor Relations
(269) 686-1709
ajshannon@perrigo.com